NVIDIA has launched more than two dozen new microservices for healthcare enterprises to tap into the latest advancements in generative AI (GenAI) from any location and across any cloud platform.
The 25 new microservices narrows the gap between cutting-edge technology and patient well-being, making the future of medicine a whole lot smarter.
The suite includes optimised NVIDIA NIM AI models and workflows, complete with industry-standard application programming interfaces (APIs). These APIs serve as the fundamental building blocks for creating and deploying cloud-native applications. They offer advanced imaging, natural language and speech recognition, and digital biology generation, prediction and simulation.
NVIDIA’s software development kits and tools, including Parabricks, MONAI, NeMo, Riva and Metropolis, can now be accessed as NVIDIA CUDA-X microservices to accelerate healthcare workflows for drug discovery, medical imaging and genomics analysis.
The suite can accelerate transformation for healthcare companies as GenAI introduces numerous opportunities for pharmaceutical companies, doctors and hospitals. These include screening for trillions of drug compounds to advance medicine, gathering better patient data to aid early disease detection, and implementing smarter digital assistants.
Researchers, developers, and practitioners can seamlessly integrate these microservices into both new and existing applications. Whether deployed in the cloud or on-premises, they come equipped with copilot capabilities, augmenting their life-saving impact.
“By helping healthcare companies easily build and manage AI solutions, we’re enabling them to harness the full power and potential of generative AI,” said Kimberly Powell, Vice President of Healthcare at NVIDIA.
Entelechy Asia 